41715-70-2

Usage

Chemical structure

Not provided in the material

Usage

Solvent in various industrial applications, commonly used in paint and coating formulations, adhesives and sealants production, and as a reaction medium and extraction solvent in the pharmaceutical and agrochemical industries

Hazard classification

Hazardous substance, with potential health risks associated with its exposure, including irritation to the skin, eyes, and respiratory system

Environmental impact

Considered a volatile organic compound (VOC) and is subject to regulation to prevent its release into the environment.

Upstream product

• 1984-59-4 2,3-dichloroanisole 
• 141-75-3 butyryl chloride 

Downstream Products

• 41715-71-3 (E)-methyl-{2,3-dichloro-4-[3-(2-ethyl-3-phenyl)acryloyl]}phenyl ether 
• 41715-73-5 2-ethyl-3-phenyl-5-hydroxy-6,7-dichloro-1-indanone 

Relevant academic research and scientific papers

A two-aromatic substituted propylene ketone compound and its preparation method and application (by machine translation)

The present invention discloses a two-aromatic substituted propylene ketone compound and its preparation method and application, its structural formula such as formula (I) as shown: Wherein A is B is hydrogen, methyl or ethyl; C is a substituted benzene ring, pyridine and furan heterocyclic, 2 - pyridyl, 3 - pyridyl, 4 - pyridyl, 5 - 1 H - indolyl, 4 - (N, N - dimethylamino) phenyl, 4 - (N - pyrrolyl) phenyl, 4 - [1 - (N - methyl piperazinyl)] phenyl or 4 - (1 - morpholinyl) phenyl. The compounds of the invention has a novel structure, to inhibit the cells MCL active effect, high safety, the preparation cost is low and the like, can be used as a MCL very promising drug. (by machine translation)

[1-Oxo-2-halo(or hydrogen) indanyloxy]-alkanoic acid

[1-Oxo-2-halo(or hydrogen)indanyloxy(or thio)]-alkanoic acid products and salts, esters and amide derivatives where the indanyl ring may be further substituted with from 2 to 5 nuclear substituents. The [1-oxo-2-haloindanyloxy-(or thio)]alkanoic acids are prepared (1) via the halogenation of a [1-oxoindanyloxy(or thio)]alkanoic acid or (2) via the addition of halogen to a [1-oxoindenyloxy(or thio)]-alkanoic acid. The [1-oxoindanyloxy(or thio)]alkanoic acids are prepared (1) via cyclialkylation of a (2-alkylideneacyl)-phenoxy(or thio)alkanoic acid or (2) via etherification of a hydroxy(or mercapto)-2-alkyl-1-indanone. The [1-oxo-2-halo(or hydrogen)indanyloxy(or thio)]alkanoic acids are diuretics and saluretics. In addition, some of these compounds are also able to maintain the uric acid concentration in the body at pretreatment level or to cause a decrease in uric acid concentration.

[1-Hydroxy-5-indanyloxy (or thio)]-alkanoic acids

[1-Hydroxy-5-indanyloxy (or thio)]alkanoic acids and their salts, esters and amides are disclosed. The products display a dual pharmaceutical utility in that they exhibit diuretic, saluretic and hypouricemic activity. The acid products are prepared by several synthetic methods.